Form 8-K ANTARES PHARMA, INC. For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Antares Pharma (ATRS) Reports In-Line Q2 Loss
August 7, 2014 7:19 AM EDTAntares Pharma (NASDAQ: ATRS) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.43 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
... More